Las Vegas, NV -- (SBWIRE) -- 01/10/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Canadian Solar Inc.(NASDAQ:CSIQ), XOMA Corp(NASDAQ:XOMA), Novavax, Inc.(NASDAQ:NVAX), Key Energy Services, Inc.(NYSE:KEG)
Canadian Solar Inc.(NASDAQ:CSIQ) was a volume gainer of 4.40 million shares and the average volume of the stock remained 3.65 million shares. The stock opened the session at $39.17 and finished at the end of the day at $36.91 and the stock plunged -3.96%.The market capitalization of the stock remained 1.60 billion. Canadian Solar Inc., together with its subsidiaries, engages in the design, development, manufacture, and sale of solar power products worldwide. The company offers solar wafers, cells, and solar module products that convert sunlight into electricity for various uses. Canadian Solar Inc. was founded in 2001 and is headquartered in West Guelph, Canada.
Has CSIQ Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, XOMA Corp(NASDAQ:XOMA) exchanged 4.39 million shares and the average volume remained 2.58 million shares. The stock closed the session at $8.17with the gain of 14.11%. XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company offers ACEON, an angiotensin converting enzyme inhibitor. XOMA Corporation was founded in 1981 and is headquartered in Berkeley, California.
Will XOMA Continue To Move Higher? Find Out Here
Novavax, Inc.(NASDAQ:NVAX) enhanced 0.39% and its closing price was $5.18. The volume of the stock was 4.38 million shares and the average volume remained 5.96 million shares. The market capitalization of the stock remained 1.08 billion. The beta of the stock remained 2.44. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. The company, through its joint venture, CPL Biologics Private Limited, engages in developing seasonal and pandemic influenza, and rabies vaccine candidates.
Why Should Investors Buy NVAX After The Recent Gain? Just Go Here and Find Out
Key Energy Services, Inc.(NYSE:KEG) exchanged 4.37 million shares in the previous trading session, and its average trading remained 2.43 million shares. KEG advanced 1.82% and it closed the trading at $7.28. The market capitalization of the stock remained 1.11 billion. Key Energy Services, Inc. operates as an onshore rig-based well servicing contractor in the United States and internationally. The company offers rig-based services, including the maintenance, workover, and plugging and abandonment of wells at the end of their lives, as well as specialty drilling services to oil and natural gas producers.
For How Long KEG’s Gloss will Attract Investors? Find out via this report
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)